Patents Assigned to UNIVERSITE CLERMONT AUVERGNE
  • Patent number: 11198814
    Abstract: A method of manufacturing nanoparticles of a photoluminescent material, including the successive steps of: a) forming nanometer-range particles of said photoluminescent material; b) forming a dispersion containing the particles in a non-aqueous solvent, the dispersion further containing at least one surface agent; c) placing the dispersion in an autoclave at a pressure in the range from 2 MPa to 100 MPa; and d) recovering the particles.
    Type: Grant
    Filed: June 30, 2017
    Date of Patent: December 14, 2021
    Assignees: Aledia, Université Clermont Auvergne, Centre National de la Recherche Scientifique, Sigma Clermont
    Inventors: Abdelhay Aboulaich, Geneviève Chadeyron, Rachid Mahiou
  • Patent number: 11191744
    Abstract: The invention relates to an active pharmaceutical ingredient consisting exclusively of the combination of (1S,3R,4R,5R)-3-{[(2E)-3-(3,4-)dihydroxyphenyl)-2-propenoyl]oxy}-1,4,5-trihydroxycyclohexanecarboxylic acid and of methyl (2S,3E,4S)-4-{2-[2-(3,4-dihydroxyphenyl)ethoxy]-2-oxoethyl}-3-ethylidene-2-(?-D-glucopyranosyloxy)-3,4-dihydro-2H-pyran-5-carboxylate for use as a drug or veterinary product, particularly in the prevention and/or treatment of pathological disorders of carbohydrate and/or lipid metabolism.
    Type: Grant
    Filed: February 13, 2018
    Date of Patent: December 7, 2021
    Assignees: VALBIOTIS, UNIVERSITE CLERMONT AUVERGNE, UNIVERSITE DE LA ROCHELLE, CNRS
    Inventors: Sebastien Peltier, Vivien Chavanelle, Florian Le Joubioux, Pascal Sirvent, Thierry Maugard
  • Patent number: 11185567
    Abstract: Gastro-intestinal release capsule intended for oral use in a method for desensitizing and/or inducing tolerance in a peanut-allergic subject or, alternatively, for diagnosing a peanut allergy in a subject. The capsule has a shell and a core, the core has a composition of peanut including peanut, at least one oil, at least one first pulverulent excipient and, optionally, at least one second prebiotic excipient. The capsule is provided and ingested in an unopened form.
    Type: Grant
    Filed: February 9, 2018
    Date of Patent: November 30, 2021
    Assignees: CENTRE HOSPITALIER ET UNIVERSITAIRE DE CLERMONT-FERRAND, UNIVERSITE CLERMONT AUVERGNE
    Inventors: Jean-Luc Fauquert, Bertrand Evrard, Elodie Michaud, Etienne Merlin
  • Patent number: 10813965
    Abstract: A composition comprising at least a mixture of molecules extracted from Chrysanthellum indicum, Cynara scolymus and Lycium barbarum. This composition is in particular useful as a nutritional product or health product to prevent and/or combat fat and/or carbohydrate metabolism disorders in Humans or animals.
    Type: Grant
    Filed: October 20, 2016
    Date of Patent: October 27, 2020
    Assignees: VALBIOTIS, UNIVERSITE CLERMONT AUVERGNE
    Inventors: Sebastien Peltier, Vivien Chavanelle, Pascal Sirvent
  • Patent number: 10751385
    Abstract: The present invention relates to the use of gasdermin, in particular of gasdermin A, gasdermin B, gasdermin C, gasdermin D, DFNA5 or DFNB59 (or pejvakin), and more particularly pejvakin for modulating cellular redox homeostasis. A particularly preferred use of gasdermin, in particular of gasdermin A, gasdermin B, gasdermin C, gasdermin D, DFNA5 or DFNB59 (or pejvakin), and more particularly pejvakin in the context of the present invention is as an antioxidant. The present invention also concerns a virally-mediated gene therapy for restoring genetically-impaired auditory and vestibular functions in subjects suffering from an Usher syndrome. More precisely, this gene therapy takes advantage of an AAV2/8 vector expressing at least one USH1 gene product, preferably SANS.
    Type: Grant
    Filed: February 19, 2016
    Date of Patent: August 25, 2020
    Assignees: Institut Pasteur, Centre National de la Recherche Scientifique (CNRS), Sorbonne Université, Université Clermont Auvergne
    Inventors: Christine Petit, Paul Avan, Sedigheh Delmaghani, Jean Defourny, Asadollah Aghaie, Saaid Safieddine, Alice Emptoz
  • Patent number: 10736930
    Abstract: A composition comprising at least: a single extract obtained from a mixture of at least two plants selected from Chrysanthellum indicum, Cynara scolymus, Vaccinium myrtillus, Piper and Olea europaea. This composition is particularly useful as a nutritional product or health product for preventing and/or combating carbohydrate and/or fat metabolism disorders in humans and animals.
    Type: Grant
    Filed: October 30, 2018
    Date of Patent: August 11, 2020
    Assignees: VALBIOTIS, UNIVERSITE CLERMONT AUVERGNE, UNIVERSITE DE LA ROCHELLE, CNRS
    Inventors: Sebastien Peltier, Pascal Sirvent, Thierry Maugard
  • Patent number: 10633587
    Abstract: A method for producing a photo-luminescent material, including the following steps: (1) producing, according to a sol-gel method, a sol and then a gel of first precursors of a first substance from the sol; (2) crushing the gel; (3) optionally, annealing the gel in order to form first particles of the first substance of which the average size is between 1 pm and 20 um; (4) producing a colloidal dispersion of second particles of a second substance, different from the first substance or identical to the first substance, of which the average size is between 5 nm and 400 nm; (5) mixing the colloidal dispersion with the sol in step (1) before forming the gel or with the first particles after step (3); and (6) annealing the mixture obtained in step (5), resulting in an increase in the compactness of the mixture, the average size of the second particles after annealing being between 100 nm and 900 nm.
    Type: Grant
    Filed: August 12, 2015
    Date of Patent: April 28, 2020
    Assignees: Aledia, Universite Clermont Auvergne, Centre National de la Recherche Scientifique, Sigma Clermont
    Inventors: Abdelhay Aboulaich, Geneviève Chadeyron, Rachid Mahiou
  • Patent number: 10549013
    Abstract: The invention relates to an implant material for filling bone defects, for bone regeneration, and for bone tissue engineering, to an implant comprising said material, and to methods for manufacturing such an implant. The hybrid implant material according to the invention comprises: a biodegradable polymer P soluble in at least one solvent S1 and insoluble in at least one solvent S, different from the solvent S1; and a bioactive glass made of SiO2 and CaO and optionally containing P2O5 and/or optionally doped with strontium, characterized in that said implant includes a layering of a porous part having more than 90% by number of pores whose largest dimension is greater than or equal to 100 ?m, and a dense part (2, 20, 200, 2000, 20000) having more than 80% by number of pores whose largest dimension is less than 50 ?m. The invention is useful in the field of bone regeneration, particularly in the field of bone tissue engineering.
    Type: Grant
    Filed: September 28, 2015
    Date of Patent: February 4, 2020
    Assignees: Universite Clermont Auvergne, Centre National de la Recherche Scientifique
    Inventors: Jonathan Claude Alexandre Lao, Edouard Daniel Albert Jallot, Xavier Dieudonne
  • Patent number: 10543223
    Abstract: The present invention relates to mannose derivatives of formula (I): wherein R1 represents H, CO—(C1-C6)-alkyl or CO-alkylaryl, Y represents a single bond, CH2, O, NR3, S, A represents O, NH or S, X represents H and X? represents OH or X and X? taken together with the carbon atom bearing them form a CO group, R2 represents H, a linear or branched (C1-C6)-alkyl or CF3, R3 represents H, a C1-C6 alkyl, a CO—(C1-C6)-alkyl, CF3 or COCF3, and R is as described in claim 1.
    Type: Grant
    Filed: August 5, 2016
    Date of Patent: January 28, 2020
    Assignees: ENTEROME, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, UNIVERSITE CLERMONT AUVERGNE, UNIVERSITE DE NANTES
    Inventors: Sebastien Gouin, Thibault Chalopin, Julie Bouckaert, Nicolas Barnich, Adeline Sivignon, Dimitri Alexander Alvarez-Dorta, Francois Bellamy
  • Patent number: 10500245
    Abstract: A composition including at least one XAP peptide, in which X represents the empty set or a valine, for use in the prevention and/or treatment of pathologies associated with alpha-glucosidase. Also, the use of a hydrolysate of at least one protein, the protein including or constituted by at least 0.05% to <5% or of at least 5% of XAP units, in which X represents the empty set or a valine, for use in the prevention and/or treatment of pathologies associated with alpha-glucosidase.
    Type: Grant
    Filed: February 18, 2015
    Date of Patent: December 10, 2019
    Assignees: UNIVERSITE DE LA ROCHELLE, UNIVERSITE CLERMONT AUVERGNE
    Inventors: Thierry Maugard, Stephanie Bordenave-Juchereau, Jean-Marie Piot, Yesmine Ben-Henda, Pascal Sirvent, Sebastien Peltier
  • Publication number: 20190241804
    Abstract: A method of manufacturing nanoparticles of a photoluminescent material, including the successive steps of: a) forming nanometer-range particles of said photoluminescent material; b) forming a dispersion containing the particles in a non-aqueous solvent, the dispersion further containing at least one surface agent; c) placing the dispersion in an autoclave at a pressure in the range from 2 MPa to 100 MPa; and d) recovering the particles.
    Type: Application
    Filed: June 30, 2017
    Publication date: August 8, 2019
    Applicants: Aledia, Universite Clermont Auvergne, Cente National de la Recherche Scientifique
    Inventors: Abdelhay Aboulaich, Geneviève Chadeyron, Rachid Mahiou
  • Patent number: 10232005
    Abstract: A composition comprising at least a mixture of molecules obtained at least from: Chrysanthellum indicum, Cynara scolymus, and Vaccinium myrtillus and wherein the mixture of molecules also comprises piperine. The composition is particularly useful as a nutritional product or health product for preventing and/or combating carbohydrate and/or fat metabolism disorders in humans and animals.
    Type: Grant
    Filed: October 18, 2016
    Date of Patent: March 19, 2019
    Assignees: Universite Clermont Auvergne, Valbiotis, Universite De La Rochelle, CNRS
    Inventors: Sebastien Peltier, Pascal Sirvent, Thierry Maugard
  • Patent number: 10214476
    Abstract: The present invention relates to the use of compounds for the treatment or prevention of pain in mammals, in particularly in human beings, and also to a process for preparing these compounds.
    Type: Grant
    Filed: December 31, 2012
    Date of Patent: February 26, 2019
    Assignees: ECOLE NATIONALE SUPERIEURE DE CHIMIE DE CLERMONT FERRAND, UNIVERSITÉ CLERMONT AUVERGNE
    Inventors: Sylvie Ducki, Khalil Bennis, Alain Eschalier, Jérôme Busserolles, Florian Lesage, Nuno Rodrigues, Delphine Vivier
  • Patent number: 10149920
    Abstract: The disclosure relates to an implant material for filling bone defects, for bone regeneration, and for bone tissue engineering, to an implant comprising this material, to a method for producing such an implant, and to a method for producing a hybrid material. The implant material comprises a hybrid material comprising: a bioactive glass M based on SiO2 and CaO, optionally containing P2O5 and/or optionally doped with strontium, and a biodegradable polymer P soluble in a solvent and chosen from among bioresorbable polysaccharides. The implant material has applications in the medical field.
    Type: Grant
    Filed: June 3, 2014
    Date of Patent: December 11, 2018
    Assignees: UNIVERSITE CLERMONT AUVERGNE, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
    Inventors: Jonathan Claude Alexandre Lao, Joséphine Lacroix, Edouard Daniel Albert Jallot, Xavier Dieudonne
  • Patent number: 9962420
    Abstract: This disclosure provides compositions formulated in the form of tablets, wafer capsules, gel capsules, sticks, sachets, vials, droppers or in injectable form. The compositions comprise a mixture of: an extract of Chrysanthellum indicum, an extract of Cynara scolymus, an extract of Vaccinium myrtillus, an extract of Olea europaea, and pipeline. This disclosure also provides methods of treating pathological disorders of carbohydrate and/or fat metabolism in a patient by administering to the patient the compositions.
    Type: Grant
    Filed: October 20, 2015
    Date of Patent: May 8, 2018
    Assignees: VALBIOTIS, UNIVERSITE CLERMONT AUVERGNE, UNIVERSITE DE LA ROCHELLE, CNRS
    Inventors: Sebastien Peltier, Pascal Sirvent, Thierry Maugard
  • Publication number: 20170325451
    Abstract: The invention relates to the use of alkyl gallate for stimulating the natural defenses of plants and to a method for stimulating the natural defenses of plants, which includes the application of a composition including an alkyl gallate on said plants.
    Type: Application
    Filed: November 16, 2015
    Publication date: November 16, 2017
    Applicant: Université Clermont Auvergne
    Inventors: Pascale Goupil, Razik Benouaret, Claire Richard